Executives from the top toxin brands weigh in on the media response to the launch of Jeuveau. This months podcast was a live recording of the Toxin Titans Part II panel from the recent Aesthetics Innovation Summit. Dr Grant Stevens led the discussion on the risk of price erosion and commoditization as competitors enter the market. Listen in to gain perspectives on how these leaders plan to grow and differentiate themselves in a massive market that is still considered untapped.

Participants:
Dan Browne, CEO & President - Revance Therapeutics
Alisa Lask, VP & General Manager, US Aesthetic - Nestlé Skin Health (Galderma)
David Moatazedi, President & CEO - Evolus
Bob Rhatigan, CEO - Merz Americas
Carrie Strom, SVP, Medical Aesthetics - Allergan

Moderated By:
W. Grant Stevens, MD, FACS, CEO - Marina Plastic Surgery/Chief Medical Officer & Co-Founder – OrangeTwist /Clinical Professor - USC School of Medicine